In our recent effort to understand the basis for adaptation to high altitude hypoxia in human subjects, we analyzed the whole genome of Ethiopians residing at high altitude (>3,500m above sea level) for genetic variation. Humans on the Ethiopian mountains are well adapted to high altitude and do not suffer from Chronic Mountain Sickness such as those in the Andes. Using cross-population tests of selection, we identified genomic regions with significant loss of diversity in the Ethiopians, indicative of selective sweeps. Indeed, we discovered a number of such DNA regions on several chromosomes with specific genes embedded in them. In order to elucidate the potential role of these genes in hypoxia response and tolerance, we experimentally tested whether these genes were involved in hypoxia, in either Drosophila melanogaster or mice, thus providing additional evidence for their role in hypoxia in humans. One of these DNA selected regions on chromosome 13 harbored the gene Endothelin Receptor B (EDNRB). In mammals, this gene encodes for a receptor for an endothelin ligand, a potent vasoactive peptide that activates a signaling cascade that promotes blood vessel constriction. Since a) there is literature showing that inhibition of endothelin receptors is beneficial for adaptation to high altitude hypoxia, especially regarding pulmonary hypertension and b) EDNRB is present mostly in the cardiovascular system (CV), we focus this proposal on the study of EDNRB and the effects of its down-regulation on the CV system and on the cellular and molecular acute responses to hypoxia. Towards this goal, we have created an EDNRB knock-down in mice (EDNRB+/-) to study the role of this particular gene in the CV system in acute hypoxia. Our overall hypothesis is that EDNRB plays an important protective role in acute hypoxic stress. This hypothesis will be addressed in the experiments of the following Specific Aims:
Specific Aim 1 : Study the cardiovascular (CV) function in EDNRB+/- and demonstrate that EDNRB down-regulation or inhibition preserves CV function in acute hypoxia as compared to wild type mice.
Specific Aim 2 : Dissect the molecular mechanisms that are fundamental to the preservation of the CV function during acute hypoxia in EDNRB+/- mice.

Public Health Relevance

This application addresses an important set of specific aims focused on understanding how the heart and the cardiovascular system function when an individual mammal is stressed with low oxygen in their blood. We have previously discovered that a gene, EDNRB, is important in humans at high altitude but did not know the details of this relation. In this application, we have preliminary data to show that it can preserve heart function even when there is severe lack of oxygen. Further, we are studying how this is achieved when this gene is down-regulated or inhibited.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL127403-02
Application #
9283637
Study Section
Myocardial Ischemia and Metabolism Study Section (MIM)
Program Officer
Laposky, Aaron D
Project Start
2016-06-01
Project End
2020-02-29
Budget Start
2017-03-01
Budget End
2018-02-28
Support Year
2
Fiscal Year
2017
Total Cost
$387,500
Indirect Cost
$137,500
Name
University of California San Diego
Department
Pediatrics
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Stobdan, Tsering; Akbari, Ali; Azad, Priti et al. (2017) New Insights into the Genetic Basis of Monge's Disease and Adaptation to High-Altitude. Mol Biol Evol 34:3154-3168